Lurking beneath the shiny promise of artificial intelligence in health care is a host of potential liability issues, experts ...

CMS and ASTP, the health department’s health IT regulator, released a request for information this week about existing ...

Good morning! Despite believing that headlines on STAT stories are “terrible,” former FDA head Robert Califf said at ...

Roche warned that President Trump's executive order on drug pricing threatens its planned $50 billion investment in the ...

Biotech investors are preparing for what may be the most important clinical trial readout for them this summer.

Lowering drug prices to European benchmarks would ultimately reduce innovation and cost American consumers just over half a ...

The health of Native American communities is under threat because of massive cuts to federal health services, tribal leaders ...

In hours of combative congressional hearings Wednesday, health secretary Robert F. Kennedy Jr. swung between defending ...

The mood at the annual meeting of the American Society of Cell and Gene Therapy isn’t amazing. The biotech market has been ...

Ex-FDA chief Robert Califf about HHS Secretary Robert F. Kennedy Jr. — “My primary worry is not the FDA, my worry is the ...

The scientists at the University of California, San Francisco and Johns Hopkins University in Baltimore injected an antisense ...

If 14 million lost coverage, that would push the total number of uninsured in the U.S. close to pre-Affordable Care Act ...